Chronic Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Kidney Disease stocks.

Chronic Kidney Disease Stocks Recent News

Date Stock Title
May 10 SNY Fed rates, Tesla Supercharger backpedal, Novavax's 'new chapter': Market Domination
May 10 SNY Sanofi vaccine deal kicks off Novavax's 'new chapter': Analyst
May 10 SNY Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
May 10 SNY Novavax stock doubles after Sanofi deal marks 'new chapter' for company
May 10 AKBA Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
May 10 AKBA Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
May 10 SNY Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
May 10 SNY Why Novavax Stock More Than Doubled Today
May 10 LSTA Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
May 10 LSTA Q1 2024 Lisata Therapeutics Inc Earnings Call
May 10 SNY Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
May 10 SNY Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
May 10 ARDX Ardelyx: Strong Execution, Fairly Valued
May 10 SNY Novavax-Sanofi vaccine deal, Yelp and Sweetgreen earnings: Morning Brief
May 10 SNY Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi
May 10 SNY Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
May 10 SNY Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
May 10 SNY Update: Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar
May 10 SNY Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
May 10 SNY Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
Chronic Kidney Disease

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

Browse All Tags